Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome

被引：0
|
作者：
Kibum Kim
Daniel R. Touchette
Larisa H. Cavallari
Amer K. Ardati
Robert J. DiDomenico
机构：
[1] University of Utah,Department of Pharmacotherapy and Pharmacotherapy Outcomes Research Center
[2] University of Illinois at Chicago,Center for Pharmacoepidemiology and Pharmacoeconomic Research
[3] University of Illinois at Chicago,Department of Pharmacy Systems, Outcomes and Policy
[4] University of Florida,Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics
[5] University of Illinois at Chicago,Division of Cardiology
[6] University of Illinois at Chicago,Department of Pharmacy Practice
来源：
Cardiovascular Drugs and Therapy | 2019年 / 33卷
关键词：
Acute coronary syndrome; Personalized medicine; Ticagrelor; Clopidogrel; P2Y; inhibitors; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：533 / 546
页数：13
相关论文
共 50 条
  • [31] P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
    De Filippo, Ovidio
    D'Ascenzo, Fabrizio
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Peyracchia, Mattia
    Bocchino, Pier Paolo
    Kinnaird, Tim
    Ariza-Sole, Albert
    Liebetrau, Christoph
    Manzano-Fernandez, Sergio
    Boccuzzi, Giacomo
    Simao Henriques, Jose Paulo
    Templin, Christian
    Wilton, Stephen B.
    Omede, Pierluigi
    Velicki, Lazar
    Xanthopoulou, Ioanna
    Correia, Luis
    Cerrato, Enrico
    Rognoni, Andrea
    Fabrizio, Ugo
    Nunez-Gil, Ivan
    Iannaccone, Mario
    Montabone, Andrea
    Taha, Salma
    Fujii, Toshiharu
    Durante, Alessandro
    Song, Xiantao
    Gili, Sebastiano
    Magnani, Giulia
    Varbella, Ferdinando
    Kawaji, Tetsuma
    Flores Blanco, Pedro
    Garay, Alberto
    Quadri, Giorgio
    Alexopoulos, Dimitrios
    Caneiro Queija, Berenice
    Huczek, Zenon
    Cobas Paz, Rafael
    Gonzalez Juanatey, Jose Ramon
    Cespon Fernandez, Maria
    Nie, Shao-Ping
    Munoz Pousa, Isabel
    Kawashiri, Masa-Aki
    Gallo, Diego
    Morbiducci, Umberto
    Conrotto, Federico
    Montefusco, Antonio
    Dominguez-Rodriguez, Alberto
    Lopez-Cuenca, Angel
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (01) : 31 - 42
  • [32] Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
    Luo, Li-Man
    Pang, Zhan-Qi
    Fu, Meng-Lu
    Li, Yuan-Yuan
    Tu, Ling
    Xu, Xi-Zhen
    CHINESE MEDICAL JOURNAL, 2020, 133 (21) : 2628 - 2629
  • [33] Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
    Luo Li-Man
    Pang Zhan-Qi
    Fu Meng-Lu
    Li Yuan-Yuan
    Tu Ling
    Xu Xi-Zhen
    中华医学杂志英文版, 2020, 133 (21) : 2628 - 2629
  • [34] Meta-Analysis of the Relative Efficacy and Safety of Oral P2Y12 Inhibitors in Patients With Acute Coronary Syndrome
    Shah, Rahman
    Rashid, Abdul
    Hwang, Inyong
    Fan, Tai-Hwang M.
    Khouzam, Rami N.
    Reed, Guy L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (11): : 1723 - 1728
  • [35] In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors
    Akinci, Sinan
    Coner, Ali
    Akbay, Ertan
    Adar, Adem
    Muderrisoglu, Haldun
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (05): : 320 - 326
  • [36] P2Y12 inhibitors in acute coronary syndrome: relation to hemorrhagic events in routine clinical practice
    Godinho, A. R.
    Viana, M.
    Correia, S.
    Dias, P.
    Almeida, R.
    Aszczynska, O.
    Araujo, C.
    Moreira, I.
    Maciel, M. J.
    Azevedo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 108 - 108
  • [37] P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use
    Grotti, Simone
    Bolognese, Leonardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 : E9 - E12
  • [38] Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population
    Hou, Mingxi
    Hyun, Karice
    Chew, Derek P.
    Kritharides, Leonard
    Amos, David
    Brieger, David
    HEART LUNG AND CIRCULATION, 2022, 31 (08): : 1085 - 1092
  • [39] Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes
    Chatzizisis, Yiannis S.
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (04) : 382 - 385
  • [40] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Is Clinically Justified
    Valgimigli, Marco
    CIRCULATION, 2014, 130 (21) : 1891 - 1903
12345